Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy NextCure stock
Learn how to easily invest in NextCure stock.
NextCure is a biotechnology business based in the US. NextCure shares (NXTC) are listed on the NASDAQ and all prices are listed in US Dollars. NextCure employs 87 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy NextCure stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NXTC. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
NextCure stock price (NASDAQ: NXTC)Use our graph to track the performance of NXTC stocks over time.
NextCure shares at a glance
|Latest market close||$1.63|
|52-week range||$1.16 - $5.54|
|50-day moving average||$1.48|
|200-day moving average||$3.23|
|Wall St. target price||$5.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.66|
Buy NextCure stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy NextCure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
NextCure price performance over time
|1 week (2023-01-26)||1.24%|
|1 month (2022-12-30)||15.60%|
|3 months (2022-11-02)||-34.01%|
|6 months (2022-08-02)||-62.00%|
|1 year (2022-02-01)||-71.30%|
|2 years (2021-02-02)||-86.66%|
|3 years (2020-01-31)||42.75|
|5 years (2018-01-29)||N/A|
|Gross profit TTM||$-4,081,000|
|Return on assets TTM||-21%|
|Return on equity TTM||-34.61%|
|Market capitalisation||$45.3 million|
TTM: trailing 12 months
NextCure share dividends
We're not expecting NextCure to pay a dividend over the next 12 months.
NextCure share price volatility
Over the last 12 months, NextCure 's shares have ranged in value from as little as $1.16 up to $5.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NextCure 's is -0.0234. This would suggest that NextCure 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, NextCure has bucked the trend.
NextCure, Inc. , a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc.
Frequently asked questionsWhat percentage of NextCure is owned by insiders or institutions?
Currently 8.758% of NextCure shares are held by insiders and 62.263% by institutions. How many people work for NextCure ?
Latest data suggests 87 work at NextCure . When does the fiscal year end for NextCure ?
NextCure 's fiscal year ends in December. Where is NextCure based?
NextCure 's address is: 9000 Virginia Manor Road, Beltsville, MD, United States, 20705 What is NextCure 's ISIN number?
NextCure 's international securities identification number is: US65343E1082 What is NextCure 's CUSIP number?
NextCure 's Committee on Uniform Securities Identification Procedures number is: 65343E108
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert